title: Amifostine and chemoradiation therapy: ASCO responds.
authors.affiliation: University of Pennsylvania, PA, USA.
authors.forename: Lynn
authors.initials: L
authors.lastname: Schuchter
authors.forename: Neal J
authors.initials: NJ
authors.lastname: Meropol
authors.forename: Eric P
authors.initials: EP
authors.lastname: Winer
authors.forename: Martee L
authors.initials: ML
authors.lastname: Hensley
authors.forename: Mark R
authors.initials: MR
authors.lastname: Somerfield
mesh_terms: D004999:Amifostine / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D009061:Mouth Mucosa / Q000187:drug effects / Q000528:radiation effects; D017410:Practice Guidelines as Topic; D011878:Radiotherapy / Q000009:adverse effects*; D014987:Xerostomia / Q000188:drug therapy*
chemical_list: D004999:Amifostine